LAUSANNE, Switzerland--(BUSINESS WIRE)--ADC Therapeutics SA (NYSE: ADCT), a commercial-stage biotechnology company improving the lives of those affected by cancer with its next-generation, targeted ...
Agree Realty Corporation (ADC) will begin trading ex-dividend on November 29, 2021. A cash dividend payment of $0.227 per share is scheduled to be paid on December 14, 2021. Shareholders who purchased ...
Welcome to the ADC Therapeutics Fourth Quarter and Year End 2021 Financial Results Conference Call. My name is Josh and I will be your operator for today's call. At this time, all participants are in ...
The new ADC Therapeutics drug, Zynlonta, is a treatment for diffuse large cell B-cell lymphoma (DLBCL). According to deal terms announced Thursday, ADC Therapeutics will receive $225 million when the ...
MUNICH & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) will present new breast cancer research data across its DXd ADC portfolio at the 2021 San ...
Agree Realty Corporation (ADC) will begin trading ex-dividend on August 30, 2021. A cash dividend payment of $0.217 per share is scheduled to be paid on September 14, 2021. Shareholders who purchased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback